Physiotherapy in Patients With Stable Chronic Obstructive Pulmonary Disease
Launched by UNIVERSIDAD DE GRANADA · Aug 4, 2015
Trial Information
Current as of May 15, 2025
Completed
Keywords
ClinConnect Summary
Chronic obstructive pulmonary disease (COPD) is one of the leading diseases causing mortality and morbidity, despite advanced pharmacotherapy and therapeutic management. Although COPD primarily affects the lungs, it also implies extrapulmonary manifestations, such as nutritional depletion, skeletal muscle dysfunction, and abnormal respiratory muscles.
Pulmonary rehabilitation is widely used to treat COPD patients and it has been shown that pulmonary rehabilitation should be implemented at all COPD stages, bringing them benefits in terms of improved exercise capacity, symptoms, and quality ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • COPD diagnosis
- • No contraindication of physiotherapy.
- • Signed written consent.
- • Medical approval for inclusion.
- Exclusion Criteria:
- • Acute exacerbation in the previous month
- • Contraindications of physiotherapy.
- • Neurological, orthopedic or heart disease.
About Universidad De Granada
The Universidad de Granada is a prestigious academic institution in Spain, renowned for its commitment to research and innovation in the medical and health sciences. With a strong emphasis on interdisciplinary collaboration, the university engages in a wide range of clinical trials designed to advance medical knowledge and improve patient care. Its dedicated team of researchers and clinicians work closely to ensure the ethical conduct and scientific rigor of all trials, contributing to the advancement of evidence-based medicine. The Universidad de Granada is dedicated to fostering an environment that promotes excellence in research, ultimately aiming to translate findings into clinical practice for the benefit of society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Granada, , Spain
Patients applied
Trial Officials
Marie Carmen Valenza, PhD
Principal Investigator
Universidad de Granada
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials